J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text HTML] [Full Text PDF] （in Japanese / 79KB） [Members Only]

J.Jpn. Surg. Soc.. 106(8): 472-478, 2005

Feature topic

TREATMENT FOR PANCREATIC ENDOCRINE TUMORS WITH OR WITHOUTMULTIPLE ENDOCRINE NEOPLASIA TYPE 1

Professor Emeritus Kyoto University, Director Osaka Saiseikai Noe Hospital, Osaka, Japan

Masayuki Imamura

Recent strategies for the treatment of pancreatic endocrine tumors are described. Most cases are metastatic, and liver metastasis is the most significant prognostic factor. Thus curative resection before liver metastasis develops based on the localization of the tumors with the SASI test is the standard strategy. Subtotal distal pancreatectomy or pancreas-preserving total duodenectomy is indicated for multiple pancreatic endocrine tumors and multiple duodenal gastrinomas, respectively, for patients with multiple endocrine neoplasia type 1.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.